Global Medication Reference Center
Quick access to official brand and generic medication labeling, regulatory status, generic-equivalence resources, and country-specific product registries for practitioners.
The search term is carried to supported official databases. Some registries may require you to paste the copied term into their own search field.
DailyMed Drug Labels
Current in-use prescription and nonprescription labeling submitted to FDA, including indications, dosing, warnings, adverse reactions, interactions, pregnancy information, and product identifiers.
Drugs@FDA
Search FDA-approved human drugs by drug name, active ingredient, or application number. Includes approval history, labeling, regulatory information, and FDA reviews when available.
FDA Orange Book
Use for FDA therapeutic-equivalence evaluations, approved generic products, dosage forms, strengths, patents, exclusivity, and application information.
RxNorm / RxNav
National Library of Medicine terminology for connecting brand names, generic ingredients, strengths, dose forms, and normalized medication concepts.
NAFDAC Greenbook
Nigeria’s registered product database. Search by product name, active ingredient, NAFDAC registration number, applicant, manufacturer, dosage form, route, strength, and approval status.
Medication Alternatives
Generic equivalents should be confirmed through regulatory equivalence sources. Therapeutic alternatives are different drugs that may serve a similar clinical purpose but require review of indication, evidence, contraindications, organ function, interactions, formulary, cost, and patient preference.
Regional Medication Registries
The NKN architecture is prepared to add authoritative registries for other African countries, Europe, the United Kingdom, Canada, Asia, Latin America, and the Middle East as official sources are validated.
Expansion registry under development
Practitioner safety notice
This center is a discovery and reference gateway, not a prescribing engine. Verify the complete current monograph, approved indication, formulation, strength, route, patient-specific factors, local registration status, and applicable treatment guidelines. Brand availability and formulation can differ by country. Do not interpret a therapeutic-class match as automatic interchangeability.